Copyright Reports & Markets. All rights reserved.

Global Nicotinamide Riboside (NR) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Nicotinamide Riboside (NR)
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Nicotinamide Riboside (NR) Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Purity ≤98%
    • 1.3.3 Purity ＞98%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Nicotinamide Riboside (NR) Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Health Supplement
    • 1.4.3 Pharmaceutical Additives
  • 1.5 Global Nicotinamide Riboside (NR) Market Size & Forecast
    • 1.5.1 Global Nicotinamide Riboside (NR) Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Nicotinamide Riboside (NR) Sales Quantity (2018-2029)
    • 1.5.3 Global Nicotinamide Riboside (NR) Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 ChromaDex
    • 2.1.1 ChromaDex Details
    • 2.1.2 ChromaDex Major Business
    • 2.1.3 ChromaDex Nicotinamide Riboside (NR) Product and Services
    • 2.1.4 ChromaDex Nicotinamide Riboside (NR) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 ChromaDex Recent Developments/Updates
  • 2.2 Genex Formulas
    • 2.2.1 Genex Formulas Details
    • 2.2.2 Genex Formulas Major Business
    • 2.2.3 Genex Formulas Nicotinamide Riboside (NR) Product and Services
    • 2.2.4 Genex Formulas Nicotinamide Riboside (NR) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Genex Formulas Recent Developments/Updates
  • 2.3 Shandong Tianming Pharmaceutical
    • 2.3.1 Shandong Tianming Pharmaceutical Details
    • 2.3.2 Shandong Tianming Pharmaceutical Major Business
    • 2.3.3 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Product and Services
    • 2.3.4 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Shandong Tianming Pharmaceutical Recent Developments/Updates
  • 2.4 Bontac
    • 2.4.1 Bontac Details
    • 2.4.2 Bontac Major Business
    • 2.4.3 Bontac Nicotinamide Riboside (NR) Product and Services
    • 2.4.4 Bontac Nicotinamide Riboside (NR) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Bontac Recent Developments/Updates
  • 2.5 Longer Livetech
    • 2.5.1 Longer Livetech Details
    • 2.5.2 Longer Livetech Major Business
    • 2.5.3 Longer Livetech Nicotinamide Riboside (NR) Product and Services
    • 2.5.4 Longer Livetech Nicotinamide Riboside (NR) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Longer Livetech Recent Developments/Updates
  • 2.6 Tiantai Biotechnology
    • 2.6.1 Tiantai Biotechnology Details
    • 2.6.2 Tiantai Biotechnology Major Business
    • 2.6.3 Tiantai Biotechnology Nicotinamide Riboside (NR) Product and Services
    • 2.6.4 Tiantai Biotechnology Nicotinamide Riboside (NR) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Tiantai Biotechnology Recent Developments/Updates
  • 2.7 EnzymeWorks
    • 2.7.1 EnzymeWorks Details
    • 2.7.2 EnzymeWorks Major Business
    • 2.7.3 EnzymeWorks Nicotinamide Riboside (NR) Product and Services
    • 2.7.4 EnzymeWorks Nicotinamide Riboside (NR) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 EnzymeWorks Recent Developments/Updates
  • 2.8 Suzhou MyLand Pharm & Nutrition
    • 2.8.1 Suzhou MyLand Pharm & Nutrition Details
    • 2.8.2 Suzhou MyLand Pharm & Nutrition Major Business
    • 2.8.3 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Product and Services
    • 2.8.4 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Suzhou MyLand Pharm & Nutrition Recent Developments/Updates
  • 2.9 Shenzhen Ejion Biotechnology
    • 2.9.1 Shenzhen Ejion Biotechnology Details
    • 2.9.2 Shenzhen Ejion Biotechnology Major Business
    • 2.9.3 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Product and Services
    • 2.9.4 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Shenzhen Ejion Biotechnology Recent Developments/Updates
  • 2.10 Zhejiang Jiahua
    • 2.10.1 Zhejiang Jiahua Details
    • 2.10.2 Zhejiang Jiahua Major Business
    • 2.10.3 Zhejiang Jiahua Nicotinamide Riboside (NR) Product and Services
    • 2.10.4 Zhejiang Jiahua Nicotinamide Riboside (NR) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Zhejiang Jiahua Recent Developments/Updates
  • 2.11 Weitai Pharmaceutical
    • 2.11.1 Weitai Pharmaceutical Details
    • 2.11.2 Weitai Pharmaceutical Major Business
    • 2.11.3 Weitai Pharmaceutical Nicotinamide Riboside (NR) Product and Services
    • 2.11.4 Weitai Pharmaceutical Nicotinamide Riboside (NR) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Weitai Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Nicotinamide Riboside (NR) by Manufacturer

  • 3.1 Global Nicotinamide Riboside (NR) Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Nicotinamide Riboside (NR) Revenue by Manufacturer (2018-2023)
  • 3.3 Global Nicotinamide Riboside (NR) Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Nicotinamide Riboside (NR) by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Nicotinamide Riboside (NR) Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Nicotinamide Riboside (NR) Manufacturer Market Share in 2022
  • 3.5 Nicotinamide Riboside (NR) Market: Overall Company Footprint Analysis
    • 3.5.1 Nicotinamide Riboside (NR) Market: Region Footprint
    • 3.5.2 Nicotinamide Riboside (NR) Market: Company Product Type Footprint
    • 3.5.3 Nicotinamide Riboside (NR) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Nicotinamide Riboside (NR) Market Size by Region
    • 4.1.1 Global Nicotinamide Riboside (NR) Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Nicotinamide Riboside (NR) Consumption Value by Region (2018-2029)
    • 4.1.3 Global Nicotinamide Riboside (NR) Average Price by Region (2018-2029)
  • 4.2 North America Nicotinamide Riboside (NR) Consumption Value (2018-2029)
  • 4.3 Europe Nicotinamide Riboside (NR) Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Nicotinamide Riboside (NR) Consumption Value (2018-2029)
  • 4.5 South America Nicotinamide Riboside (NR) Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Nicotinamide Riboside (NR) Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Nicotinamide Riboside (NR) Sales Quantity by Type (2018-2029)
  • 5.2 Global Nicotinamide Riboside (NR) Consumption Value by Type (2018-2029)
  • 5.3 Global Nicotinamide Riboside (NR) Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Nicotinamide Riboside (NR) Sales Quantity by Application (2018-2029)
  • 6.2 Global Nicotinamide Riboside (NR) Consumption Value by Application (2018-2029)
  • 6.3 Global Nicotinamide Riboside (NR) Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Nicotinamide Riboside (NR) Sales Quantity by Type (2018-2029)
  • 7.2 North America Nicotinamide Riboside (NR) Sales Quantity by Application (2018-2029)
  • 7.3 North America Nicotinamide Riboside (NR) Market Size by Country
    • 7.3.1 North America Nicotinamide Riboside (NR) Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Nicotinamide Riboside (NR) Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Nicotinamide Riboside (NR) Sales Quantity by Type (2018-2029)
  • 8.2 Europe Nicotinamide Riboside (NR) Sales Quantity by Application (2018-2029)
  • 8.3 Europe Nicotinamide Riboside (NR) Market Size by Country
    • 8.3.1 Europe Nicotinamide Riboside (NR) Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Nicotinamide Riboside (NR) Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Nicotinamide Riboside (NR) Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Nicotinamide Riboside (NR) Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Nicotinamide Riboside (NR) Market Size by Region
    • 9.3.1 Asia-Pacific Nicotinamide Riboside (NR) Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Nicotinamide Riboside (NR) Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Nicotinamide Riboside (NR) Sales Quantity by Type (2018-2029)
  • 10.2 South America Nicotinamide Riboside (NR) Sales Quantity by Application (2018-2029)
  • 10.3 South America Nicotinamide Riboside (NR) Market Size by Country
    • 10.3.1 South America Nicotinamide Riboside (NR) Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Nicotinamide Riboside (NR) Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Nicotinamide Riboside (NR) Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Nicotinamide Riboside (NR) Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Nicotinamide Riboside (NR) Market Size by Country
    • 11.3.1 Middle East & Africa Nicotinamide Riboside (NR) Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Nicotinamide Riboside (NR) Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Nicotinamide Riboside (NR) Market Drivers
  • 12.2 Nicotinamide Riboside (NR) Market Restraints
  • 12.3 Nicotinamide Riboside (NR) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Nicotinamide Riboside (NR) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Nicotinamide Riboside (NR)
  • 13.3 Nicotinamide Riboside (NR) Production Process
  • 13.4 Nicotinamide Riboside (NR) Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Nicotinamide Riboside (NR) Typical Distributors
  • 14.3 Nicotinamide Riboside (NR) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Nicotinamide Riboside (NR) market size was valued at USD 22 million in 2022 and is forecast to a readjusted size of USD 38 million by 2029 with a CAGR of 8.0% during review period.
    Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. Nicotinamide Riboside(NR) is white or light yellow crystalline powder, odorless, bitter and slightly hygroscopic.
    In fact, the market’s mainstream is selling NRC powder, the full name called nicotinamide riboside chloride. NRC is a chloride form of NR. 100 mg of nicotinamide riboside chloride provides about 88 mg of nicotinamide riboside. The report focuses on the Nicotinamide Riboside(NR) market, which has been converted.
    The global Nicotinamide Riboside (NR) market was valued at US$ 21.46 million in 2022 and will reach US$ 38.76 million by the end of 2029, growing at a CAGR of 8.32% during 2023-2029.
    The data for 2023 is an estimate, based on the historical data and the integrated view of industrial experts, manufacturers, distributors, and end users, etc.
    Top-down and bottom-up approaches are used to validate the global Nicotinamide Riboside (NR) market size and to estimate the market size for company, regional division, product type and application (end users). In the complete market engineering process, both top-down and bottom-up approaches along with several data triangulation methods have been extensively utilized to perform market estimation and market forecast for the overall market division and subdivision listed in this report. Extensive qualitative and further quantitative analysis has also been done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
    Global key players of Nicotinamide Riboside (NR) include ChromaDex, Genex Formulas, Shandong Tianming Pharmaceutical, Bontac, Longer Livetech, etc. The top three players hold a share over 60%.
    Asia-Pacific is the largest market, has a share about 39%, followed by North America, and Europe, with share 35% and 16%, separately.
    In terms of product type, purity below 98% is the largest segment, occupied for a share of 63%, and in terms of application, health supplement has a share about 92 percent.
    The Global Info Research report includes an overview of the development of the Nicotinamide Riboside (NR) industry chain, the market status of Health Supplement (Purity ≤98%, Purity ＞98%), Pharmaceutical Additives (Purity ≤98%, Purity ＞98%), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Nicotinamide Riboside (NR).
    Regionally, the report analyzes the Nicotinamide Riboside (NR) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Nicotinamide Riboside (NR) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Nicotinamide Riboside (NR) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Nicotinamide Riboside (NR) industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (MT), revenue generated, and market share of different by Type (e.g., Purity ≤98%, Purity ＞98%).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Nicotinamide Riboside (NR) market.
    Regional Analysis: The report involves examining the Nicotinamide Riboside (NR) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Nicotinamide Riboside (NR) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Nicotinamide Riboside (NR):
    Company Analysis: Report covers individual Nicotinamide Riboside (NR) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Nicotinamide Riboside (NR) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Health Supplement, Pharmaceutical Additives).
    Technology Analysis: Report covers specific technologies relevant to Nicotinamide Riboside (NR). It assesses the current state, advancements, and potential future developments in Nicotinamide Riboside (NR) areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Nicotinamide Riboside (NR) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Nicotinamide Riboside (NR) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    Purity ≤98%
    Purity ＞98%
    Market segment by Application
    Health Supplement
    Pharmaceutical Additives
    Major players covered
    ChromaDex
    Genex Formulas
    Shandong Tianming Pharmaceutical
    Bontac
    Longer Livetech
    Tiantai Biotechnology
    EnzymeWorks
    Suzhou MyLand Pharm & Nutrition
    Shenzhen Ejion Biotechnology
    Zhejiang Jiahua
    Weitai Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Nicotinamide Riboside (NR) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Nicotinamide Riboside (NR), with price, sales, revenue and global market share of Nicotinamide Riboside (NR) from 2018 to 2023.
    Chapter 3, the Nicotinamide Riboside (NR) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Nicotinamide Riboside (NR) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Nicotinamide Riboside (NR) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Nicotinamide Riboside (NR).
    Chapter 14 and 15, to describe Nicotinamide Riboside (NR) sales channel, distributors, customers, research findings and conclusion.

    Buy now